Velox Peptides supplies DSIP at 99% HPLC-verified purity as a lyophilised research reagent for in vitro use by qualified researchers
Brian Buijsse, et al Glutathione Arabidopsis Book
This is a separate and still investigational line of research rather than an established use, and it should not be confused with the fat-loss mechanism that the bulk of the clinical work has focused on
Without FDA approval, prescribing such a substance could be considered malpractice, risking their licenses and legal action
That does not mean BPC-157 has no role around painful joints
Researchers believe this reduction may partly contribute to slower healing, collagen loss, inflammation, tissue degeneration, and visible signs of aging